ARS | Publication request: The emerging role of krüppel-like factors in endocrine-responsive cancers of female reproductive tissues

Submitted to: Endocrinology
Publication Type: Review Article
Publication Acceptance Date: September 25, 2009
Publication Date: March 15, 2010
Citation: Simmen, R.C., Pabona, J.M., Velarde, M., Simmons, C.D., Rahal, O., Simmen, F.A. 2010. The emerging role of krüppel-like factors in endocrine-responsive cancers of female reproductive tissues. Endocrinology. 204(3):223-231.

Technical Abstract: Krüppel-like factors (KLFs), of which there are currently 17 known protein members, belong to the Specificity-protein (Sp) family of transcription factors and are characterized by the presence of Cys2/His2 zinc-finger motifs in their carboxy-terminal domains that confer preferential binding to GC/GT-rich sequences in gene promoter and enhancer regions. While previously regarded to simply function as silencers of Sp1-transactivity, many KLFs are now shown to be relevant to human cancers by their newly identified abilities to mediate cross-talk with signaling pathways involved in the control of cell proliferation, apoptosis, migration, and differentiation. Several KLFs act as tumor suppressors and/or oncogenes under distinct cellular contexts, underscoring their prognostic potential for cancer survival and outcome. Recent studies suggest that a number of KLFs can influence steroid hormone signaling through transcriptional networks involving steroid hormone receptors and members of the nuclear receptor family of transcription factors. Since inappropriate sensitivity or resistance to steroid hormone actions underlie endocrine-related malignancies, we consider the intriguing possibility that dysregulation of expression and/or activity of KLF members is linked to the pathogenesis of endometrial and breast cancers. In this review, we focus on recently described mechanisms of actions of several KLFs (KLF4, KLF5, KLF6, and KLF9) in cancers of the mammary gland and uterus. We suggest that understanding the mode of actions of KLFs and their functional networks may lead to the development of novel therapeutics to improve current prospects for cancer prevention and cure.